
Endocrinologist

No OPD information available
Low Blood Sugar
Type 1 Diabetes (T1D)
Diabetic Ketoacidosis
Type 2 Diabetes (T2D)
ADULT Syndrome
Diabetic Retinopathy
Low Potassium Level
Peripheral Neuropathy
Pneumonia
David N. O'neal is a male healthcare provider who helps people with various health conditions like Low Blood Sugar, Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Type 2 Diabetes (T2D), ADULT Syndrome, Diabetic Retinopathy, Low Potassium Level, Peripheral Neuropathy, and Pneumonia.
David N. O'neal uses special skills and treatments to care for patients with these health issues. He communicates with patients in a way that makes them feel comfortable and trust him. Patients appreciate his caring and knowledgeable approach to their health.
To stay updated with the latest medical knowledge, David N. O'neal reads research articles and attends medical conferences. He values learning new things to provide the best care for his patients.
David N. O'neal works well with other medical professionals, collaborating and sharing knowledge to improve patient outcomes. His relationships with colleagues are positive, and they work together to provide comprehensive care.
David N. O'neal's work has positively impacted many patients' lives by helping them manage their health conditions effectively. His dedication and expertise have made a difference in the health and well-being of those he treats.
One of David N. O'neal's notable publications is "A Call-to-Action to Eliminate Barriers to Accessing Automated Insulin Delivery Systems for People with Type 1 Diabetes," published in Diabetes technology & therapeutics. He has also conducted clinical trials, such as "Feasibility of an Investigational Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Participants."
Overall, David N. O'neal is a compassionate and skilled healthcare provider who is dedicated to improving the health and lives of his patients through his expertise and commitment to staying informed about the latest medical advancements.
Enrollment Status: Completed
Published: March 07, 2023
Intervention Type: Device
Study Drug:
Study Phase: Not Applicable
